Comparison of the epidemiology of invasive pneumococcal disease between Australia and New Zealand in 2017–2021: an observational study based on surveillance data

Wahl, 2018, Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15, Lancet Glob Health, 6, e744, 10.1016/S2214-109X(18)30247-X Meder, 2020, Long-term impact of pneumococcal conjugate vaccines on invasive disease and pneumonia hospitalizations in indigenous and non-indigenous Australians, Clin Infect Dis, 70, 2607, 10.1093/cid/ciz731 Petousis-Harris, 2019, Pneumococcal conjugate vaccines turning the tide on inequity: a retrospective cohort study of New Zealand children born 2006–2015, Clin Infect Dis, 68, 818, 10.1093/cid/ciy570 2019, Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper –February 2019, Wkly Epidemiol Rec, 94, 85 2021 Isturiz, 2017, Streptococcus pneumoniae serotype 19A: worldwide epidemiology, Expert Rev Vaccines, 16, 1007, 10.1080/14760584.2017.1362339 Anglemyer, 2021, Invasive pneumococcal disease: concerning trends in serotype 19A notifications in New Zealand, Clin Infect Dis, 74, 1859, 10.1093/cid/ciab766 Savulescu, 2022, Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study, Vaccine, 40, 3963, 10.1016/j.vaccine.2022.05.011 Desmet, 2021, Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study, Lancet Infect Dis, 21, 127, 10.1016/S1473-3099(20)30173-0 Brandileone, 2021, Dynamics of antimicrobial resistance of Streptococcus pneumoniae following PCV10 introduction in Brazil: nationwide surveillance from 2007 to 2019, Vaccine, 39, 3207, 10.1016/j.vaccine.2021.02.063 Severiche-Bueno, 2021, Burden of invasive pneumococcal disease (IPD) over a 10-year period in Bogotá, Colombia, Int J Infect Dis, 105, 32, 10.1016/j.ijid.2021.02.031 Potin, 2016, Opinión del Comité Consultivo de Inmunizaciones Sociedad Chilena de Infectología: vacuna neumocóccica conjugada en niños y la emergencia de serotipo 19A, Rev Chil Infectol, 33, 304, 10.4067/S0716-10182016000300009 Tantawichien, 2022, Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas, Expert Rev Vaccines, 21, 215, 10.1080/14760584.2022.2016399 Brueggemann, 2021, Lancet Digit Health, 3, e360, 10.1016/S2589-7500(21)00077-7 Rothman, 2012 Keyfitz, 1966, 3. Sampling variance of standardized mortality rates, Hum Biol, 38, 309 2020 Feikin, 2013, Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites, PLoS Med, 10, 10.1371/journal.pmed.1001517 Weinberger, 2011, Serotype replacement in disease after pneumococcal vaccination, Lancet, 378, 1962, 10.1016/S0140-6736(10)62225-8 Brandileone, 2018, Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil, Vaccine, 36, 2559, 10.1016/j.vaccine.2018.04.010 Camacho Moreno, 2020, Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10, Hum Vaccin Immunother, 16, 2300, 10.1080/21645515.2019.1710411 Peckeu, 2021, Impact and effectiveness of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children under 5 years of age in The Netherlands, Vaccine, 39, 431, 10.1016/j.vaccine.2020.11.018 Rinta-Kokko, 2018, Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland, Vaccine, 36, 1934, 10.1016/j.vaccine.2018.03.001 Choi, 2008, Streptococcus pneumoniae serotype 19A in children, South Korea, Emerg Infect Dis, 14, 275, 10.3201/eid1402.070807 Dagan, 2009, Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population, J Infect Dis, 199, 776, 10.1086/597044 Lassi, 2021, The impact of the COVID-19 pandemic on immunization campaigns and programs: a systematic review, Int J Environ Res Public Health, 18, 988, 10.3390/ijerph18030988